The use of inhaled prostacyclin in nitroprusside-resistant pulmonary artery hypertension.
about
PDE5A inhibitor treatment of persistent pulmonary hypertension after mechanical circulatory support.Inhaled epoprostenol for the treatment of pulmonary arterial hypertension in critically ill adults.Pathophysiology and potential treatments of pulmonary hypertension due to systolic left heart failure.Comparison of drugs for pulmonary hypertension reversibility testing: A meta-analysis.The effects of oral acetylsalicylic acid on blood fluidity and infusion speed in the cancer patients with PICC.
P2860
The use of inhaled prostacyclin in nitroprusside-resistant pulmonary artery hypertension.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
The use of inhaled prostacyclin in nitroprusside-resistant pulmonary artery hypertension.
@en
The use of inhaled prostacyclin in nitroprusside-resistant pulmonary artery hypertension.
@nl
type
label
The use of inhaled prostacyclin in nitroprusside-resistant pulmonary artery hypertension.
@en
The use of inhaled prostacyclin in nitroprusside-resistant pulmonary artery hypertension.
@nl
prefLabel
The use of inhaled prostacyclin in nitroprusside-resistant pulmonary artery hypertension.
@en
The use of inhaled prostacyclin in nitroprusside-resistant pulmonary artery hypertension.
@nl
P2093
P1476
The use of inhaled prostacyclin in nitroprusside-resistant pulmonary artery hypertension.
@en
P2093
P304
P356
10.1016/S1053-2498(01)00320-5
P577
2001-12-01T00:00:00Z